Belumosudil in patients with bronchiolitis obliterans syndrome phenotype of chronic lung allograft dysfunction: An exploratory single-center real-world retrospective study.

Abstract excerpt

BACKGROUND: Chronic lung allograft dysfunction (CLAD) is a major cause of post-lung transplant mortality, with limited medical treatment options. This exploratory single-center real-world retrospective study aimed to evaluate the clinical outcomes and safety of belumosudil in lung transplant recipients with the bronchiolitis obliterans syndrome (BOS) phenotype of CLAD. METHODS: An exploratory single-center...

Topics

• Humans
• Lung Transplantation
• Female
• Retrospective Studies
• Male
• Bronchiolitis Obliterans Syndrome